Google
Trusted Resources: News & Events
Latest announcements and gatherings
DDCF Awards $6 Million for Sickle Cell Disease Research
The Doris Duke Charitable Foundation has announced grants totaling $6 million in support of seven research projects addressing the causes of sickle cell disease.
Sickle cell disease, the most common inherited blood disorder in the United States, affects approximately a hundred thousand Americans. Patients with sickle cell disease carry dysfunctional red blood cells that alter regular blood flow, which translates into pain, poor organ oxygenation and organ damage, and a life span of only about forty years.
The first grants awarded through DDCF’s Sickle Cell Disease/Advancing Cures awards competition will support projects designed to develop disease-modifying approaches to sickle cell disease and translate them into clinically feasible therapies. By restoring hemoglobin function, researchers aim to remove patients’ need to manage the disease’s acute, devastating, and lifelong symptoms, ultimately increasing their life expectancy.
+myBinderRelated Content
-
Jeff Glassberg, MDDr. Jeffrey Glassberg obtained his MD an...
-
Opioid Abuse Backlash Could Hurt Sickle Cell Patients’ Medication Needs, Some FearWith drug overdoses now the leading caus...
-
Healthy red blood cells owe their shape to muscle-like structuresRed blood cells are on a wild ride. As t...
-
Lewis Hsu, MD, PhDDr. Lewis Hsu is a pediatric hematologis...
-
Women with Sickle Cell Disease and Postpartum Care: What to Know After Delivering Your BabyPostpartum care is health care you get a...
-
Johns Hopkins Berman Institute of BioethicsEstablished in 1995, the Berman Institut...
-
Men with sickle cell disease show significant concerns over safety while being treated for vaso-occlusive crises: pr...Background: We undertook a large multisi...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.